59.35
Finanzdaten der Ionis Pharmaceuticals Inc-Aktie (IONS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
243.47%
452.05
|
131.61 | 226.58 | 133.81 | 225.25 |
Cost Of Revenue |
183.73%
4.151
|
1.463 | 3.83 | 1.071 | 4.164 |
Gross Profit |
244.14%
447.90
|
130.15 | 222.75 | 132.74 | 221.09 |
|
11.22%
308.08
|
277.01 | 337.40 | 281.40 | 287.18 |
Interest Income/Expense |
0.15%
4.114
|
4.108 | 4.191 | 4.161 | 4.49 |
Benefits Costs and Expenses |
17.99%
328.52
|
278.43 | 337.40 | 277.92 | 291.45 |
Costs And Expenses |
12.12%
312.23
|
278.47 | 337.40 | 282.47 | 291.34 |
Operating Income/Loss |
195.20%
139.82
|
-146.86 | -110.82 | -148.66 | -66.09 |
Income/Loss From Continuing Operations Before Tax |
184.14%
123.53
|
-146.82 | -110.82 | -144.10 | -66.20 |
Income Tax Expense/Benefit |
117.24%
-0.02
|
0.116 | -2.69 | -3.621 | 0.064 |
Income/Loss From Continuing Operations After Tax |
184.08%
123.55
|
-146.94 | -104.35 | -140.48 | -66.27 |
|
184.08%
123.55
|
-146.94 | -104.35 | -140.48 | -66.27 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.25%
159.14
|
158.74 | 2.811 | 148.59 | 145.96 |
Diluted Average Shares |
14.87%
182.33
|
158.74 | 2.811 | 148.59 | 145.96 |
Basic Earnings Per Share |
183.87%
0.78
|
-0.93 | -0.66 | -0.95 | -0.45 |
Diluted Earnings Per Share |
175.27%
0.70
|
-0.93 | -0.66 | -0.95 | -0.45 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):